메뉴 건너뛰기




Volumn 12, Issue 6, 2009, Pages 909-914

Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in the Netherlands during 2000 to 2004

Author keywords

Diabetes mellitus; Diabetes related complications; Direct costs; Pharmacy; Prevention and control

Indexed keywords

ANTIDIABETIC AGENT; CARDIOVASCULAR AGENT; INSULIN; ORAL ANTIDIABETIC AGENT;

EID: 67651236019     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2009.00506.x     Document Type: Article
Times cited : (6)

References (23)
  • 1
    • 2942666483 scopus 로고    scopus 로고
    • WHO. Available from. [Accessed September 9, 2008].
    • WHO. Diabetes mellitus. 2006. Available from: http://www.who.int/ mediacentre/factsheets/fs312/en/index.html [Accessed September 9, 2008].
    • (2006) Diabetes Mellitus
  • 3
    • 33846414720 scopus 로고    scopus 로고
    • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. the task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the study of diabetes (EASD)
    • Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the study of diabetes (EASD). Eur Heart J 2007 28 : 88 136.
    • (2007) Eur Heart J , vol.28 , pp. 88-136
    • Ryden, L.1    Standl, E.2    Bartnik, M.3
  • 4
    • 0036833536 scopus 로고    scopus 로고
    • Inside guidelines: Comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries
    • Burgers JS, Bailey JV, Klazinga NS, et al. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 2002 25 : 1933 9.
    • (2002) Diabetes Care , vol.25 , pp. 1933-1939
    • Burgers, J.S.1    Bailey, J.V.2    Klazinga, N.S.3
  • 5
    • 33645124529 scopus 로고    scopus 로고
    • NHG-standaard diabetes mellitus type 2 (tweede herziening) (NHG practice guideline diabetes mellitus type 2 (second revision)
    • Rutten GEHM, De Grauw WJC, Nijpels G, et al. NHG-standaard diabetes mellitus type 2 (tweede herziening) (NHG practice guideline diabetes mellitus type 2 (second revision). Huisarts Wet 2006 49 : 137 52.
    • (2006) Huisarts Wet , vol.49 , pp. 137-152
    • Gehm, R.1    De Grauw, W.J.C.2    Nijpels, G.3
  • 6
    • 33846025092 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
    • Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007 30 : 162 72.
    • (2007) Diabetes Care , vol.30 , pp. 162-172
    • Buse, J.B.1    Ginsberg, H.N.2    Bakris, G.L.3
  • 7
    • 5344249310 scopus 로고    scopus 로고
    • The CORE Diabetes Model
    • Suppl.
    • Brandle M, Herman WH. The CORE Diabetes Model. Curr Med Res Opin 2004 20 (Suppl. 1 S1 3.
    • (2004) Curr Med Res Opin , vol.20 , Issue.1 , pp. 1-3
    • Brandle, M.1    Herman, W.H.2
  • 8
    • 5344261712 scopus 로고    scopus 로고
    • The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making
    • Suppl.
    • Palmer AJ, Roze S, Valentine WJ, et al. The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin 2004 20 (Suppl. 1 S5 26.
    • (2004) Curr Med Res Opin , vol.20 , Issue.1 , pp. 5-26
    • Palmer, A.J.1    Roze, S.2    Valentine, W.J.3
  • 9
    • 5344269410 scopus 로고    scopus 로고
    • Validation of the CORE Diabetes Model against epidemiological and clinical studies
    • Suppl.
    • Palmer AJ, Roze S, Valentine WJ, et al. Validation of the CORE Diabetes Model against epidemiological and clinical studies. Curr Med Res Opin 2004 20 (Suppl. 1 S27 40.
    • (2004) Curr Med Res Opin , vol.20 , Issue.1 , pp. 27-40
    • Palmer, A.J.1    Roze, S.2    Valentine, W.J.3
  • 10
    • 0035432608 scopus 로고    scopus 로고
    • Cardiovascular drug use and hospitalizations attributable to type 2 diabetes
    • Erkens JA, Klungel OH, Stolk RP, et al. Cardiovascular drug use and hospitalizations attributable to type 2 diabetes. Diabetes Care 2001 24 : 1428 32.
    • (2001) Diabetes Care , vol.24 , pp. 1428-1432
    • Erkens, J.A.1    Klungel, O.H.2    Stolk, R.P.3
  • 11
    • 0026578226 scopus 로고
    • Pharmaco-morbidity linkage: A feasibility study comparing morbidity in two pharmacy based exposure cohorts
    • Herings RM, Bakker A, Stricker BH, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 1992 46 : 136 40.
    • (1992) J Epidemiol Community Health , vol.46 , pp. 136-140
    • Herings, R.M.1    Bakker, A.2    Stricker, B.H.3    Nap, G.4
  • 12
    • 0033552080 scopus 로고    scopus 로고
    • The progressive cost of complications in type 2 diabetes mellitus
    • Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999 159 : 1873 80.
    • (1999) Arch Intern Med , vol.159 , pp. 1873-1880
    • Brown, J.B.1    Pedula, K.L.2    Bakst, A.W.3
  • 13
    • 8644250763 scopus 로고    scopus 로고
    • Treatment patterns and health care costs of mebeverine-treated IBS patients: A case-control study
    • Goettsch WG, van den Boom G, Breekveldt-Postma NS, et al. Treatment patterns and health care costs of mebeverine-treated IBS patients: a case-control study. Pharmacoepidemiol Drug Saf 2004 13 : 803 10.
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , pp. 803-810
    • Goettsch, W.G.1    Van Den Boom, G.2    Breekveldt-Postma, N.S.3
  • 14
    • 0034995403 scopus 로고    scopus 로고
    • An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in the Netherlands
    • Herings RM, Klungel OH. An epidemiological approach to assess the economic burden of NSAID-induced gastrointestinal events in The Netherlands. Pharmacoeconomics 2001 19 : 655 65.
    • (2001) Pharmacoeconomics , vol.19 , pp. 655-665
    • Herings, R.M.1    Klungel, O.H.2
  • 16
    • 67651229809 scopus 로고    scopus 로고
    • Statistics-Netherlands-(CBS). Voorburg/Heerlen. Statistics Netherlands (CBS)
    • Statistics-Netherlands-(CBS). Statistisch Jaarboek. Voorburg/Heerlen : Statistics Netherlands (CBS), 2004.
    • (2004) Statistisch Jaarboek.
  • 17
    • 43449108812 scopus 로고    scopus 로고
    • Economic costs of diabetes in the U.S. in 2007
    • American Diabetes Association.
    • American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008 31 : 596 615.
    • (2008) Diabetes Care , vol.31 , pp. 596-615
  • 18
    • 35848942599 scopus 로고    scopus 로고
    • Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4)
    • Martin S, Schramm W, Schneider B, et al. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4). Exp Clin Endocrinol Diabetes 2007 115 : 495 501.
    • (2007) Exp Clin Endocrinol Diabetes , vol.115 , pp. 495-501
    • Martin, S.1    Schramm, W.2    Schneider, B.3
  • 19
    • 41849140781 scopus 로고    scopus 로고
    • The impact of diabetes on prescription drug costs: The population-based Turin study
    • Bruno G, Karaghiosoff L, Merletti F, et al. The impact of diabetes on prescription drug costs: the population-based Turin study. Diabetologia 2008 51 : 795 801.
    • (2008) Diabetologia , vol.51 , pp. 795-801
    • Bruno, G.1    Karaghiosoff, L.2    Merletti, F.3
  • 20
    • 0043244907 scopus 로고    scopus 로고
    • Economic costs of diabetes in the US in 2002
    • Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003 26 : 917 32.
    • (2003) Diabetes Care , vol.26 , pp. 917-932
    • Hogan, P.1    Dall, T.2    Nikolov, P.3
  • 21
    • 33746415251 scopus 로고    scopus 로고
    • Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes
    • Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006 29 : 1300 6.
    • (2006) Diabetes Care , vol.29 , pp. 1300-1306
    • Eppens, M.C.1    Craig, M.E.2    Cusumano, J.3
  • 23
    • 0042825242 scopus 로고    scopus 로고
    • Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: The hoorn screening study
    • Spijkerman AM, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. Diabetes Care 2003 26 : 2604 8.
    • (2003) Diabetes Care , vol.26 , pp. 2604-2608
    • Spijkerman, A.M.1    Dekker, J.M.2    Nijpels, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.